Metraipolis › archive › dc_fe9215489de2
Repurposing mebendazole to reprogram oncogenic and tumor-suppressor networks: Multi-cancer insights from ENOX2, MMP2, RASSF1A, WFDC10A and METTL7A — Europe PMC PMID:41886499
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41886499
- DOI
- 10.1371/journal.pone.0345701
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T20:58:10.573Z
- SHA-256 of the archived text
befc1ae6f0bcc65459bc9bdd241991bd26f426ce777db3824ba750d8763367d6- Stable URL of this page
https://metraipolis.com/documento/dc_fe9215489de2
How to cite
Repurposing mebendazole to reprogram oncogenic and tumor-suppressor networks: Multi-cancer insights from ENOX2, MMP2, RASSF1A, WFDC10A and METTL7A — Europe PMC PMID:41886499 — Europe PMC (en), https://europepmc.org/article/MED/41886499 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fe9215489de2 (Metraipolis archive dc_fe9215489de2, sha256 befc1ae6f0bcc65459bc9bdd241991bd26f426ce777db3824ba750d8763367d6)
BibTeX
@misc{dcfe9215489de2,
title = {Repurposing mebendazole to reprogram oncogenic and tumor-suppressor networks: Multi-cancer insights from ENOX2, MMP2, RASSF1A, WFDC10A and METTL7A — Europe PMC PMID:41886499},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41886499},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fe9215489de2; sha256 befc1ae6f0bcc65459bc9bdd241991bd26f426ce777db3824ba750d8763367d6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41886499. Agents can read the archived copy with the MCP tool read_document.